Radovancevic B, Birovljev S, Frazier O H
Division of Cardiovascular Surgery, Texas Heart Institute, Houston 77225-0345.
J Heart Transplant. 1990 May-Jun;9(3 Pt 2):288-91.
In addition to rejection, complications of rejection prophylaxis and treatment are major causes of mortality and morbidity during the first year after heart transplantation. To decrease complications related to antirejection treatment, our present approach is to assess each rejection episode individually and to adjust treatment accordingly. This article presents the analysis of rejection in the last 100 patients who underwent heart transplantation at our institution.
除排斥反应外,排斥反应预防和治疗的并发症是心脏移植后第一年死亡率和发病率的主要原因。为了减少与抗排斥治疗相关的并发症,我们目前的方法是对每一次排斥反应进行单独评估,并相应地调整治疗方案。本文介绍了对我院最近100例接受心脏移植患者的排斥反应分析。